Accolade Sees FY24 Revenue $411M-$415M Vs $412.67M Est.
Portfolio Pulse from Benzinga Newsdesk
Accolade, a healthcare technology company, has provided guidance for its fiscal year 2024 revenue, projecting it to be between $411 million and $415 million. This forecast is in line with the analyst estimate of $412.67 million.
January 08, 2024 | 9:07 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Accolade's FY24 revenue guidance is consistent with analyst expectations, indicating stability in the company's financial outlook.
Accolade's revenue guidance for FY24 is very close to the analyst estimate, which suggests that the company's performance is on track with market expectations. This typically has a neutral impact on the stock price in the short term, as there are no positive or negative surprises to adjust for.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100